Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126152222 | 12615222 | 2 | F | 20151202 | 20160921 | 20160802 | 20160930 | EXP | JP-GILEAD-2016-0224862 | GILEAD | 74.00 | YR | E | F | Y | 40.00000 | KG | 20160930 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126152222 | 12615222 | 1 | PS | SOVALDI | SOFOSBUVIR | 1 | Oral | 400 MG, QD | 33600 | MG | D | 204671 | 400 | MG | TABLET | QD | |||
| 126152222 | 12615222 | 2 | SS | REBETOL | RIBAVIRIN | 1 | Oral | 400 MG, UNK | D | 0 | 400 | MG | CAPSULE | ||||||
| 126152222 | 12615222 | 3 | SS | REBETOL | RIBAVIRIN | 1 | Oral | 200 MG, QD | D | 0 | 200 | MG | CAPSULE | QD | |||||
| 126152222 | 12615222 | 4 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 1 DF, UNK | Y | U | 0 | 1 | DF | TABLET | |||||
| 126152222 | 12615222 | 5 | SS | MERCAZOLE /00022901/ | METHIMAZOLE | 1 | Unknown | 30 MG, UNK | Y | U | 0 | 30 | MG | TABLET | |||||
| 126152222 | 12615222 | 6 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 1 DF, UNK | 0 | 1 | DF | TABLET | ||||||||
| 126152222 | 12615222 | 7 | C | FERROSTEC | SODIUM FERROUS CITRATE | 1 | 2 DF, UNK | 0 | 2 | DF | TABLET | ||||||||
| 126152222 | 12615222 | 8 | C | LOSARTAN /01121602/ | LOSARTAN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126152222 | 12615222 | 1 | Chronic hepatitis C |
| 126152222 | 12615222 | 2 | Chronic hepatitis C |
| 126152222 | 12615222 | 4 | Hyperuricaemia |
| 126152222 | 12615222 | 5 | Hyperthyroidism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126152222 | 12615222 | HO |
| 126152222 | 12615222 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126152222 | 12615222 | Atrial fibrillation | |
| 126152222 | 12615222 | Cardiac failure congestive | |
| 126152222 | 12615222 | Drug eruption | |
| 126152222 | 12615222 | Haemoglobin abnormal | |
| 126152222 | 12615222 | Hyperthyroidism | |
| 126152222 | 12615222 | Mitral valve incompetence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126152222 | 12615222 | 1 | 20151104 | 20160127 | 0 | |
| 126152222 | 12615222 | 2 | 20151104 | 20151202 | 0 | |
| 126152222 | 12615222 | 3 | 20151203 | 20160127 | 0 | |
| 126152222 | 12615222 | 4 | 20160313 | 0 | ||
| 126152222 | 12615222 | 5 | 201603 | 0 | ||
| 126152222 | 12615222 | 6 | 20160401 | 0 | ||
| 126152222 | 12615222 | 7 | 20160401 | 0 |